Coherent, Inc. Reports Fourth Fiscal Quarter and Year-End Results
SANTA CLARA, Calif., Nov. 2, 2016 /PRNewswire/ -- Coherent, Inc. (NASDAQ: COHR), a world leader in providing lasers and laser-based technology for scientific, commercial and industrial customers, today announced financial results for its fourth fiscal quarter and fiscal year ended October 1, 2016.
FINANCIAL HIGHLIGHTS
|
Three Months Ended |
Year Ended | ||||||||||||||||||
|
Oct. 1, 2016 |
July 2, 2016 |
Oct. 3, 2015 |
Oct. 1, 2016 |
Oct. 3, 2015 | |||||||||||||||
|
GAAP Results |
|||||||||||||||||||
|
(in millions except per share data) |
|||||||||||||||||||
|
Net sales |
$ |
248.5 |
$ |
218.8 |
$ |
209.6 |
$ |
857.4 |
$ |
802.5 |
|||||||||
|
Net income |
$ |
30.8 |
$ |
18.7 |
$ |
27.3 |
$ |
87.5 |
$ |
76.4 |
|||||||||
|
Diluted EPS |
$ |
1.25 |
$ |
0.76 |
$ |
1.10 |
$ |
3.58 |
$ |
3.06 |
|||||||||
|
Non-GAAP Results |
|||||||||||||||||||
|
(in millions except per share data) |
|||||||||||||||||||
|
Net income |
$ |
40.5 |
$ |
26.2 |
$ |
31.2 |
$ |
115.9 |
$ |
97.1 |
|||||||||
|
Diluted EPS |
$ |
1.65 |
$ |
1.07 |
$ |
1.25 |
$ |
4.75 |
$ |
3.89 |
|||||||||
FOURTH FISCAL QUARTER AND FISCAL YEAR DETAILS
For the fourth fiscal quarter ended October 1, 2016, Coherent announced net sales of $248.5 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $30.8 million, or $1.25 per diluted share. These results compare to net sales of $209.6 million and net income of $27.3 million, or $1.10 per diluted share, for the fourth quarter of fiscal 2015.
Non-GAAP net income for the fourth quarter of fiscal 2016 was $40.5 million, or $1.65 per diluted share. Non-GAAP net income for the fourth quarter of fiscal 2015 was $31.2 million, or $1.25 per diluted share. Reconciliations of GAAP to non-GAAP financial measures for the three months ended October 1, 2016, July 2, 2016 and October 3, 2015, and for the fiscal years ended October 1, 2016 and October 3, 2015 appear in the financial statements portion of this release under the heading "Reconciliation of GAAP to Non-GAAP net income."
Net sales for the third quarter of fiscal 2016 were $218.8 million and net income, on a GAAP basis, was $18.7 million, or $0.76 per diluted share. Non-GAAP net income for the third quarter of fiscal 2016 was $26.2 million, or $1.07 per diluted share.
Ending backlog expected to ship in the next 12 months was $605.3 million at October 1, 2016, compared to a backlog of $564.5 million at July 2, 2016 and a backlog of $309.5 million at October 3, 2015.
For the fiscal year ended October 1, 2016, Coherent posted net sales of $857.4 million and net income of $87.5 million, or $3.58 per diluted share, on a GAAP basis compared to the prior year net sales of $802.5 million and net income on a GAAP basis of $76.4 million, or $3.06 per diluted share. For the fiscal year ended October 1, 2016, Coherent posted net income on a non-GAAP basis of $115.9 million, or $4.75 per diluted share, compared to the prior year net income on a non-GAAP basis of $97.1 million, or $3.89 per diluted share.
As previously announced, on March 16, 2016, Coherent entered into a definitive agreement to acquire Rofin-Sinar Technologies, Inc. ("Rofin"), one of the world's leading developers and manufacturers of high-performance industrial laser sources and laser-based solutions and components. The acquisition will be an all-cash transaction at a price of $32.50 per share of Rofin common stock for a total approximate offer value of $942 million before fees and transaction costs. Pending completion of certain administrative matters, Coherent expects to close its acquisition of Rofin within the first few weeks of November, 2016.
"Coherent had a very strong fourth fiscal quarter that capped a record setting year. Mix and volume were favorably aligned, especially within our FPD business, enabling us to handily exceed the high end of our long-term EBITDA goals. Record backlog and a strong order pipeline have us very well positioned for fiscal 2017," said John Ambroseo, Coherent's President and CEO. "We are also pleased to have received clearance from the European Commission to complete the acquisition of Rofin conditional on the divestment of Rofin's low-power CO2 business in Hull, England." Ambroseo added.
Coherent ended the year with cash, cash equivalents and short term investments of $400.0 million, an increase of $26.4 million from cash, cash equivalents and short term investments of $373.6 million at July 2, 2016.
CONFERENCE CALL REMINDER
The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company's website at http://www.coherent.com/Investors/. For those who are not able to listen to the live broadcast, the call will be archived for approximately three months on the Company's website. A transcript of management's prepared remarks can be found at http://www.coherent.com/Investors/.
Summarized statement of operations information is as follows (unaudited, in thousands, except per share data):
|
Three Months Ended |
Year Ended | ||||||||||||||
|
Oct. 1, 2016 |
July 2, 2016 |
Oct. 3, 2015 |
Oct. 1, 2016 |
Oct. 3, 2015 | |||||||||||
|
Net Sales |
$ |
248,461 |
$ |
218,767 |
$ |
209,622 |
$ |
857,385 |
$ |
802,460 |
|||||
|
Cost of sales(A)(B)(E)(G)(H) |
134,125 |
124,208 |
118,628 |
475,993 |
467,061 |
||||||||||
|
Gross profit |
114,336 |
94,559 |
90,994 |
381,392 |
335,399 |
||||||||||
|
Operating expenses: |
|||||||||||||||
|
Research & development(A)(B) |
20,265 |
21,441 |
19,988 |
81,801 |
81,455 |
||||||||||
|
Selling, general & administrative(A)(B)(F) |
45,168 |
46,256 |
36,052 |
169,138 |
149,829 |
||||||||||
|
Gain from business combination (C) |
— |
— |
(1,316) |
— |
(1,316) |
||||||||||
|
Impairment of investment (D) |
— |
— |
— |
— |
2,017 |
||||||||||
|
Amortization of intangible assets(E) |
864 |
574 |
658 |
2,839 |
2,667 |
||||||||||
|
Total operating expenses |
66,297 |
68,271 |
55,382 |
253,778 |
234,652 |
||||||||||
|
Income from operations |
48,039 |
26,288 |
35,612 |
127,614 |
100,747 |
||||||||||
|
Other income (expense), net(B)(J) |
(3,568) |
852 |
(1,876) |
(4,718) |
(1,179) |
||||||||||
|
Income before income taxes |
44,471 |
27,140 |
33,736 |
122,896 |
99,568 |
||||||||||
|
Provision for income taxes (I) |
13,686 |
8,490 |
6,434 |
35,394 |
23,159 |
||||||||||
|
Net income |
$ |
30,785 |
$ |
18,650 |
$ |
27,302 |
$ |
87,502 |
$ |
76,409 |
|||||
|
Net income per share: |
|||||||||||||||
|
Basic |
$ |
1.27 |
$ |
0.77 |
$ |
1.11 |
$ |
3.62 |
$ |
3.09 |
|||||
|
Diluted |
$ |
1.25 |
$ |
0.76 |
$ |
1.10 |
$ |
3.58 |
$ |
3.06 |
|||||
|
Shares used in computations: |
|||||||||||||||
|
Basic |
24,244 |
24,192 |
24,632 |
24,142 |
24,754 |
||||||||||
|
Diluted |
24,582 |
24,467 |
24,914 |
24,415 |
24,992 |
||||||||||
|
(A) |
Stock-based compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands, except per share data): |
|
Stock-based compensation expense |
Three Months Ended |
Year Ended | |||||||||||||
|
Oct. 1, 2016 |
July 2, 2016 |
Oct. 3, 2015 |
Oct. 1, 2016 |
Oct. 3, 2015 | |||||||||||
|
Cost of sales |
$ |
682 |
$ |
677 |
$ |
593 |
$ |
2,558 |
$ |
2,530 |
|||||
|
Research & development |
622 |
610 |
531 |
2,268 |
1,946 |
||||||||||
|
Selling, general & administrative |
4,032 |
4,402 |
3,371 |
15,331 |
13,756 |
||||||||||
|
Impact on income from operations |
$ |
5,336 |
$ |
5,689 |
$ |
4,495 |
$ |
20,157 |
$ |
18,232 |
|||||
For the quarters ended Oct. 1, 2016, July 2, 2016 and Oct. 3, 2015, the impact on net income, net of tax was $3,890 ($0.16 per diluted share), $4,101 ($0.17 per diluted share) and $3,253 ($0.13 per diluted share), respectively. For the years ended Oct. 1, 2016 and Oct. 3, 2015, the impact on net income, net of tax was $15,261 ($0.63 per diluted share) and $13,985 ($0.56 per diluted share), respectively.
|
(B) |
Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense), net. Deferred compensation expense (benefit) included in operating results is summarized below: |
|
Deferred compensation expense (benefit) |
Three Months Ended |
Year Ended | |||||||||||||
|
Oct. 1, 2016 |
July 2, 2016 |
Oct. 3, 2015 |
Oct. 1, 2016 |
Oct. 3, 2015 | |||||||||||
|
Cost of sales |
$ |
43 |
$ |
69 |
$ |
(55) |
$ |
78 |
$ |
(13) |
|||||
|
Research & development |
167 |
330 |
(236) |
333 |
(52) |
||||||||||
|
Selling, general & administrative |
883 |
1,619 |
(1,301) |
1,719 |
(100) |
||||||||||
|
Impact on income from operations |
$ |
1,093 |
$ |
2,018 |
$ |
(1,592) |
$ |
2,130 |
$ |
(165) |
|||||
For the quarters ended Oct. 1, 2016, July 2, 2016 and Oct. 3, 2015, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $1,007, income of $1,867 and expense of $1,467, respectively. For the years ended Oct. 1, 2016 and Oct. 3, 2015, the impact on other income (expense) net from gain or losses on deferred compensation plan assets was income of $1,988 and expense of $95, respectively.
|
(C) |
For the quarter and year ended Oct. 3, 2015, the gain from business combination was $1,316 ($0.05 per diluted share). |
|
(D) |
For year ended Oct. 3, 2015, the impairment of our investment in SiOnyx, Inc., a private corporation, was $2,017 ($1,274 net of tax ($0.05 per diluted share)). |
|
(E) |
For the quarters ended Oct. 1, 2016, July 2, 2016 and Oct. 3, 2015, the impact of amortization of intangible expense was $2,249 ($1,554 net of tax ($0.06 per diluted share)), $2,032 ($1,400 net of tax ($0.06 per diluted share)) and $2,068 ($1,643 net of tax ($0.07 per diluted share)), respectively. For the years ended Oct. 1, 2016 and Oct. 3, 2015, the impact of amortization of intangible expense was $8,450 ($5,824 net of tax ($0.24 per diluted share)) and $8,244 ($6,222 net of tax ($0.25 per diluted share)), respectively. |
|
(F) |
The quarter ended Oct. 1, 2016 and July 2, 2016 included $3,177 ($2,077 net of tax ($0.08 per diluted share)) and $3,050 ($2,012 net of tax ($0.08 per diluted share)), respectively, of costs related to the recently announced agreement to acquire Rofin. The year ended Oct.1, 2016 included $9,811 ($6,353 net of tax ($0.26 per diluted share)) of costs related to the recently announced agreement to acquire Rofin. |
|
(G) |
For the quarter and year ended Oct. 3, 2015, the impact of inventory step-up costs related to acquisitions was $579 ($366 net of tax ($0.01 per diluted share)). |
|
(H) |
For the year ended Oct. 3, 2015, the impact of an accrual related to an ongoing customs audit was $1,315 ($1,289 net of tax ($0.05 per diluted share)). |
|
(I) |
The years ended Oct. 1, 2016 and Oct. 3, 2015 included $1,221 ($0.05 per diluted share) and $1,118 ($0.04 per diluted share) non-recurring tax benefit from the renewal of the R&D tax credit for fiscal 2015 and fiscal 2014, respectively. |
|
(J) |
For the quarter and year ended Oct. 1, 2016, the loss on our hedge of the Barclays debt commitment was $2,234 ($1,413 net of tax ($0.06 per diluted share)) and interest expense on the Barclays debt commitment was $1,089 ($754 net of tax ($0.03 per diluted share)). |
Summarized balance sheet information is as follows (unaudited, in thousands):
|
Oct. 1, 2016 |
Oct. 3, 2015 | |||||
|
ASSETS |
||||||
|
Current assets: |
||||||
|
Cash, cash equivalents and short-term investments |
$ |
399,953 |
$ |
325,515 |
||
|
Accounts receivable, net |
165,715 |
142,260 |
||||
|
Inventories |
212,898 |
156,614 |
||||
|
Prepaid expenses and other assets |
37,073 |
28,294 |
||||
|
Total current assets |
815,639 |
652,683 |
||||
|
Property and equipment, net |
127,443 |
102,445 |
||||
|
Other assets |
218,066 |
213,819 |
||||
|
Total assets |
$ |
1,161,148 |
$ |
968,947 |
||
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||
|
Current liabilities: |
||||||
|
Short-term borrowings |
$ |
20,000 |
$ |
— |
||
|
Accounts payable |
45,182 |
33,379 |
||||
|
Other current liabilities |
136,312 |
89,211 |
||||
|
Total current liabilities |
201,494 |
122,590 |
||||
|
Other long-term liabilities |
48,826 |
49,939 |
||||
|
Total stockholders' equity |
910,828 |
796,418 |
||||
|
Total liabilities and stockholders' equity |
$ |
1,161,148 |
$ |
968,947 |
||
|
Certain reclassifications have been made to prior year amounts to conform to the current year's presentation. |
Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, (other than per share data), net of tax):
|
Three Months Ended |
Year Ended | ||||||||||||||
|
Oct. 1, 2016 |
July 2, 2016 |
Oct. 3, 2015 |
Oct. 1, 2016 |
Oct. 3, 2015 | |||||||||||
|
GAAP net income |
$ |
30,785 |
$ |
18,650 |
$ |
27,302 |
$ |
87,502 |
$ |
76,409 |
|||||
|
Stock-based compensation expense |
3,890 |
4,101 |
3,253 |
15,261 |
13,985 |
||||||||||
|
Amortization of intangible assets |
1,554 |
1,400 |
1,643 |
5,824 |
6,222 |
||||||||||
|
Customs audit |
— |
— |
— |
— |
1,289 |
||||||||||
|
Non-recurring tax benefit |
— |
— |
— |
(1,221) |
(1,118) |
||||||||||
|
Impairment of investment |
— |
— |
— |
— |
1,274 |
||||||||||
|
Acquisition-related costs |
2,077 |
2,012 |
— |
6,353 |
— |
||||||||||
|
Interest expense on Barclays debt commitment |
754 |
— |
— |
754 |
— |
||||||||||
|
Loss on hedge of Barclays debt commitment |
1,413 |
— |
— |
1,413 |
— |
||||||||||
|
Gain from business combination |
— |
— |
(1,316) |
— |
(1,316) |
||||||||||
|
Inventory step-up on acquisition |
— |
— |
366 |
— |
366 |
||||||||||
|
Non-GAAP net income |
$ |
40,473 |
$ |
26,163 |
$ |
31,248 |
$ |
115,886 |
$ |
97,111 |
|||||
|
Non-GAAP net income per diluted share |
$ |
1.65 |
$ |
1.07 |
$ |
1.25 |
$ |
4.75 |
$ |
3.89 |
|||||
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements, as defined under the Federal securities laws. These forward-looking statements include the statements in this press release that relate to the position of the Company for 2017 and the timing of the closing of the Rofin merger. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement. Factors that could cause actual results to differ materially include risks and uncertainties, including, but not limited to, risks associated with any general market recovery, growth in demand for our products, the worldwide demand for flat panel displays, the demand for and use of the Company's products in commercial applications, our successful implementation of our customer design wins, our and our customers' exposure to risks associated with worldwide economic conditions, our customers' ability to cancel long-term purchase orders, the ability of our customers to forecast their own end markets, our ability to accurately forecast future periods, customer acceptance and adoption of our new product offerings, continued timely availability of products and materials from our suppliers, our ability to timely ship our products and our customers' ability to accept such shipments, our ability to have our customers qualify our product offerings, worldwide government economic policies, the risk the merger with Rofin may not be completed in a timely manner or at all, the failure to satisfy the conditions to consummation of the merger, the occurrence of any event, change or circumstance that could give rise to termination of the merger agreement, the effect of the announcement of the merger on business relationships, operating result and business generally, challenges and costs of closing, integrating and achieving anticipated synergies, the risk that the proposed merger disrupts current plans and operations and potential employee retention difficulties, risks related to diverting management's attention from ongoing business operations, the outcome of any legal proceedings that may be instituted related to the merger agreement, and other risks identified in the Company's and Rofin's SEC filings. Readers are encouraged to refer to the risk disclosures and critical accounting policies and estimates described in the Company's reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company. Actual results, events and performance may differ materially from those presented herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Founded in 1966, Coherent, Inc. is one of the world's leading providers of lasers and laser-based technology for scientific, commercial and industrial customers. Our common stock is listed on the Nasdaq Global Select Market and is part of the Russell 2000 and Standard & Poor's SmallCap 600 Index. For more information about Coherent, visit the Company's Web site at www.coherent.com for product and financial updates.
Logo - http://photos.prnewswire.com/prnh/20160316/345114LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/coherent-inc-reports-fourth-fiscal-quarter-and-year-end-results-300356185.html
SOURCE Coherent, Inc.